FDA Requests Comment on Proposed Information Collection for Drug Product Communications

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information for drug product communications, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.